Lymphatica Medtech develops medical devices for lymphatic disease treatment. The first product, LymphoDRAIN, is the worldwide first active lymphatic bypass for the treatment of chronic lymphedema, a disabling disease affecting millions of people worldwide.
Lymphatica developed its implantable drainage technology as a results of years of research at the Lausanne Federal Institute of Technology (EPFL) and of the Lausanne University Hospital (CHUV).
What have you learnt? Episode 3 with Lymphaticas Valentina Triacca
Lymphatica Medtech raises seven-digit Series A round
1015 Lausanne (Switzerland)